Index by author

January 01, 1996; Volume 7,Issue 1

Looking for COVID information? All ASN Journal COVID articles are in the COVID-19 Research Collection or the COVID-19 In Context Collection. All articles are free.​

A

  1. Abaterusso, C

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

  2. Acuña, G

    1. Influence of iron status in the response to the deferoxamine test.
      J B Cannata, J L Fernández-Martín, B Díaz-López, M Alonso, I Olaizola, G Acuña, C Caramelo and J Alvarez-Grande
      JASN January 1996, 7 (1) 135-139; DOI: https://doi.org/10.1681/ASN.V71135

  3. Aguilera, A

    1. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study.
      J L Teruel, R Marcen, J Navarro-Antolin, A Aguilera, G Fernandez-Juarez and J Ortuño
      JASN January 1996, 7 (1) 140-144; DOI: https://doi.org/10.1681/ASN.V71140

  4. Alonso, M

    1. Influence of iron status in the response to the deferoxamine test.
      J B Cannata, J L Fernández-Martín, B Díaz-López, M Alonso, I Olaizola, G Acuña, C Caramelo and J Alvarez-Grande
      JASN January 1996, 7 (1) 135-139; DOI: https://doi.org/10.1681/ASN.V71135

  5. Alvarez-Grande, J

    1. Influence of iron status in the response to the deferoxamine test.
      J B Cannata, J L Fernández-Martín, B Díaz-López, M Alonso, I Olaizola, G Acuña, C Caramelo and J Alvarez-Grande
      JASN January 1996, 7 (1) 135-139; DOI: https://doi.org/10.1681/ASN.V71135

  6. Anderson, S

    1. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes.
      J P Vora, S M Zimsen, D C Houghton and S Anderson
      JASN January 1996, 7 (1) 113-117; DOI: https://doi.org/10.1681/ASN.V71113

  7. Arima, S

    1. Platelet-activating factor dilates efferent arterioles through glomerulus-derived nitric oxide.
      S Arima, Y Ren, L A Juncos and S Ito
      JASN January 1996, 7 (1) 90-96; DOI: https://doi.org/10.1681/ASN.V7190

B

  1. Balletta, M M

    1. Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis.
      G Fuiano, N Comi, P Magri, V Sepe, M M Balletta, C Esposito, F Uccello, A Dal Canton and G Conte
      JASN January 1996, 7 (1) 49-55; DOI: https://doi.org/10.1681/ASN.V7149

  2. Banks, R O

    1. Role of nitric oxide and angiotensin II in diabetes mellitus-induced glomerular hyperfiltration.
      K M Mathis and R O Banks
      JASN January 1996, 7 (1) 105-112; DOI: https://doi.org/10.1681/ASN.V71105

  3. Bascands, J L

    1. Postnatal maturation of the Kallikrein-kinin system in the rat kidney: from enzyme activity to receptor gene expression.
      J L Bascands, M E Marin Castaño, G Bompart, C Pecher, M Gaucher and J P Girolami
      JASN January 1996, 7 (1) 81-89; DOI: https://doi.org/10.1681/ASN.V7181

  4. Berlin, J A

    1. Recipient body size and cadaveric renal allograft survival.
      H I Feldman, I Fazio, D Roth, J A Berlin, K Brayman, J E Burns and R A Grossman
      JASN January 1996, 7 (1) 151-157; DOI: https://doi.org/10.1681/ASN.V71151

  5. Bolander, J E

    1. Cholesterol embolization in renal allografts.
      J E Bolander and C B Carter
      JASN January 1996, 7 (1) 18-22; DOI: https://doi.org/10.1681/ASN.V7118

  6. Bompart, G

    1. Postnatal maturation of the Kallikrein-kinin system in the rat kidney: from enzyme activity to receptor gene expression.
      J L Bascands, M E Marin Castaño, G Bompart, C Pecher, M Gaucher and J P Girolami
      JASN January 1996, 7 (1) 81-89; DOI: https://doi.org/10.1681/ASN.V7181

  7. Brayman, K

    1. Recipient body size and cadaveric renal allograft survival.
      H I Feldman, I Fazio, D Roth, J A Berlin, K Brayman, J E Burns and R A Grossman
      JASN January 1996, 7 (1) 151-157; DOI: https://doi.org/10.1681/ASN.V71151

  8. Breyer, M D

    1. Functional and molecular aspects of renal prostaglandin receptors.
      M D Breyer, H R Jacobson and R M Breyer
      JASN January 1996, 7 (1) 8-17; DOI: https://doi.org/10.1681/ASN.V718

  9. Breyer, R M

    1. Functional and molecular aspects of renal prostaglandin receptors.
      M D Breyer, H R Jacobson and R M Breyer
      JASN January 1996, 7 (1) 8-17; DOI: https://doi.org/10.1681/ASN.V718

  10. Brocco, E

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

  11. Bruseghin, M

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

  12. Burkhart, K M

    1. Phospholipase A2-induced cytoprotection of proximal tubules: potential determinants and specificity for ATP depletion-mediated injury.
      R A Zager, K M Burkhart, D S Conrad, D J Gmur and M Iwata
      JASN January 1996, 7 (1) 64-72; DOI: https://doi.org/10.1681/ASN.V7164

  13. Burns, J E

    1. Recipient body size and cadaveric renal allograft survival.
      H I Feldman, I Fazio, D Roth, J A Berlin, K Brayman, J E Burns and R A Grossman
      JASN January 1996, 7 (1) 151-157; DOI: https://doi.org/10.1681/ASN.V71151

C

  1. Cannata, J B

    1. Influence of iron status in the response to the deferoxamine test.
      J B Cannata, J L Fernández-Martín, B Díaz-López, M Alonso, I Olaizola, G Acuña, C Caramelo and J Alvarez-Grande
      JASN January 1996, 7 (1) 135-139; DOI: https://doi.org/10.1681/ASN.V71135

  2. Caramelo, C

    1. Influence of iron status in the response to the deferoxamine test.
      J B Cannata, J L Fernández-Martín, B Díaz-López, M Alonso, I Olaizola, G Acuña, C Caramelo and J Alvarez-Grande
      JASN January 1996, 7 (1) 135-139; DOI: https://doi.org/10.1681/ASN.V71135

  3. Carraro, A

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

  4. Carter, C B

    1. Cholesterol embolization in renal allografts.
      J E Bolander and C B Carter
      JASN January 1996, 7 (1) 18-22; DOI: https://doi.org/10.1681/ASN.V7118

  5. Chang, P C

    1. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage.
      J van de Wetering, R G Westendorp, J G van der Hoeven, B Stolk, J D Feuth and P C Chang
      JASN January 1996, 7 (1) 145-150; DOI: https://doi.org/10.1681/ASN.V71145

  6. Comi, N

    1. Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis.
      G Fuiano, N Comi, P Magri, V Sepe, M M Balletta, C Esposito, F Uccello, A Dal Canton and G Conte
      JASN January 1996, 7 (1) 49-55; DOI: https://doi.org/10.1681/ASN.V7149

  7. Conrad, D S

    1. Phospholipase A2-induced cytoprotection of proximal tubules: potential determinants and specificity for ATP depletion-mediated injury.
      R A Zager, K M Burkhart, D S Conrad, D J Gmur and M Iwata
      JASN January 1996, 7 (1) 64-72; DOI: https://doi.org/10.1681/ASN.V7164

  8. Conte, G

    1. Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis.
      G Fuiano, N Comi, P Magri, V Sepe, M M Balletta, C Esposito, F Uccello, A Dal Canton and G Conte
      JASN January 1996, 7 (1) 49-55; DOI: https://doi.org/10.1681/ASN.V7149

  9. Crepaldi, G

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

D

  1. Dal Canton, A

    1. Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis.
      G Fuiano, N Comi, P Magri, V Sepe, M M Balletta, C Esposito, F Uccello, A Dal Canton and G Conte
      JASN January 1996, 7 (1) 49-55; DOI: https://doi.org/10.1681/ASN.V7149

  2. DeFerrari, G

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

  3. Díaz-López, B

    1. Influence of iron status in the response to the deferoxamine test.
      J B Cannata, J L Fernández-Martín, B Díaz-López, M Alonso, I Olaizola, G Acuña, C Caramelo and J Alvarez-Grande
      JASN January 1996, 7 (1) 135-139; DOI: https://doi.org/10.1681/ASN.V71135

E

  1. Eichhorn, J

    1. Circulating leukocyte integrin expression in Wegener's granulomatosis.
      H Haller, J Eichhorn, K Pieper, U Göbel and F C Luft
      JASN January 1996, 7 (1) 40-48; DOI: https://doi.org/10.1681/ASN.V7140

  2. Esposito, C

    1. Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis.
      G Fuiano, N Comi, P Magri, V Sepe, M M Balletta, C Esposito, F Uccello, A Dal Canton and G Conte
      JASN January 1996, 7 (1) 49-55; DOI: https://doi.org/10.1681/ASN.V7149

F

  1. Falk, R J

    1. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
      S L Hogan, P H Nachman, A S Wilkman, J C Jennette and R J Falk
      JASN January 1996, 7 (1) 23-32; DOI: https://doi.org/10.1681/ASN.V7123
    2. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
      P H Nachman, S L Hogan, J C Jennette and R J Falk
      JASN January 1996, 7 (1) 33-39; DOI: https://doi.org/10.1681/ASN.V7133

  2. Fazio, I

    1. Recipient body size and cadaveric renal allograft survival.
      H I Feldman, I Fazio, D Roth, J A Berlin, K Brayman, J E Burns and R A Grossman
      JASN January 1996, 7 (1) 151-157; DOI: https://doi.org/10.1681/ASN.V71151

  3. Feldman, H I

    1. Recipient body size and cadaveric renal allograft survival.
      H I Feldman, I Fazio, D Roth, J A Berlin, K Brayman, J E Burns and R A Grossman
      JASN January 1996, 7 (1) 151-157; DOI: https://doi.org/10.1681/ASN.V71151

  4. Fernandez-Juarez, G

    1. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study.
      J L Teruel, R Marcen, J Navarro-Antolin, A Aguilera, G Fernandez-Juarez and J Ortuño
      JASN January 1996, 7 (1) 140-144; DOI: https://doi.org/10.1681/ASN.V71140

  5. Fernández-Martín, J L

    1. Influence of iron status in the response to the deferoxamine test.
      J B Cannata, J L Fernández-Martín, B Díaz-López, M Alonso, I Olaizola, G Acuña, C Caramelo and J Alvarez-Grande
      JASN January 1996, 7 (1) 135-139; DOI: https://doi.org/10.1681/ASN.V71135

  6. Feuth, J D

    1. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage.
      J van de Wetering, R G Westendorp, J G van der Hoeven, B Stolk, J D Feuth and P C Chang
      JASN January 1996, 7 (1) 145-150; DOI: https://doi.org/10.1681/ASN.V71145

  7. Fioretto, P

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

  8. Fuiano, G

    1. Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis.
      G Fuiano, N Comi, P Magri, V Sepe, M M Balletta, C Esposito, F Uccello, A Dal Canton and G Conte
      JASN January 1996, 7 (1) 49-55; DOI: https://doi.org/10.1681/ASN.V7149

G

  1. Gaucher, M

    1. Postnatal maturation of the Kallikrein-kinin system in the rat kidney: from enzyme activity to receptor gene expression.
      J L Bascands, M E Marin Castaño, G Bompart, C Pecher, M Gaucher and J P Girolami
      JASN January 1996, 7 (1) 81-89; DOI: https://doi.org/10.1681/ASN.V7181

  2. Gekle, M

    1. Role of lysosomal cathepsin activities in cell hypertrophy induced by NH4Cl in cultured renal proximal tubule cells.
      H Ling, S Vamvakas, M Gekle, L Schaefer, M Teschner, R M Schaefer and A Heidland
      JASN January 1996, 7 (1) 73-80; DOI: https://doi.org/10.1681/ASN.V7173

  3. Girolami, J P

    1. Postnatal maturation of the Kallikrein-kinin system in the rat kidney: from enzyme activity to receptor gene expression.
      J L Bascands, M E Marin Castaño, G Bompart, C Pecher, M Gaucher and J P Girolami
      JASN January 1996, 7 (1) 81-89; DOI: https://doi.org/10.1681/ASN.V7181

  4. Gmur, D J

    1. Phospholipase A2-induced cytoprotection of proximal tubules: potential determinants and specificity for ATP depletion-mediated injury.
      R A Zager, K M Burkhart, D S Conrad, D J Gmur and M Iwata
      JASN January 1996, 7 (1) 64-72; DOI: https://doi.org/10.1681/ASN.V7164

  5. Göbel, U

    1. Circulating leukocyte integrin expression in Wegener's granulomatosis.
      H Haller, J Eichhorn, K Pieper, U Göbel and F C Luft
      JASN January 1996, 7 (1) 40-48; DOI: https://doi.org/10.1681/ASN.V7140

  6. Grossman, R A

    1. Recipient body size and cadaveric renal allograft survival.
      H I Feldman, I Fazio, D Roth, J A Berlin, K Brayman, J E Burns and R A Grossman
      JASN January 1996, 7 (1) 151-157; DOI: https://doi.org/10.1681/ASN.V71151

  7. Guijarro, C

    1. Cardiovascular disease after renal transplantation.
      B L Kasiske, C Guijarro, Z A Massy, M R Wiederkehr and J Z Ma
      JASN January 1996, 7 (1) 158-165; DOI: https://doi.org/10.1681/ASN.V71158

H

  1. Haller, H

    1. Circulating leukocyte integrin expression in Wegener's granulomatosis.
      H Haller, J Eichhorn, K Pieper, U Göbel and F C Luft
      JASN January 1996, 7 (1) 40-48; DOI: https://doi.org/10.1681/ASN.V7140

  2. Heidland, A

    1. Role of lysosomal cathepsin activities in cell hypertrophy induced by NH4Cl in cultured renal proximal tubule cells.
      H Ling, S Vamvakas, M Gekle, L Schaefer, M Teschner, R M Schaefer and A Heidland
      JASN January 1996, 7 (1) 73-80; DOI: https://doi.org/10.1681/ASN.V7173

  3. Hogan, S L

    1. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
      S L Hogan, P H Nachman, A S Wilkman, J C Jennette and R J Falk
      JASN January 1996, 7 (1) 23-32; DOI: https://doi.org/10.1681/ASN.V7123
    2. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
      P H Nachman, S L Hogan, J C Jennette and R J Falk
      JASN January 1996, 7 (1) 33-39; DOI: https://doi.org/10.1681/ASN.V7133

  4. Houghton, D C

    1. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes.
      J P Vora, S M Zimsen, D C Houghton and S Anderson
      JASN January 1996, 7 (1) 113-117; DOI: https://doi.org/10.1681/ASN.V71113

I

  1. Ito, S

    1. Platelet-activating factor dilates efferent arterioles through glomerulus-derived nitric oxide.
      S Arima, Y Ren, L A Juncos and S Ito
      JASN January 1996, 7 (1) 90-96; DOI: https://doi.org/10.1681/ASN.V7190

  2. Iwata, M

    1. Phospholipase A2-induced cytoprotection of proximal tubules: potential determinants and specificity for ATP depletion-mediated injury.
      R A Zager, K M Burkhart, D S Conrad, D J Gmur and M Iwata
      JASN January 1996, 7 (1) 64-72; DOI: https://doi.org/10.1681/ASN.V7164

J

  1. Jacobson, H R

    1. Functional and molecular aspects of renal prostaglandin receptors.
      M D Breyer, H R Jacobson and R M Breyer
      JASN January 1996, 7 (1) 8-17; DOI: https://doi.org/10.1681/ASN.V718

  2. Jennette, J C

    1. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
      S L Hogan, P H Nachman, A S Wilkman, J C Jennette and R J Falk
      JASN January 1996, 7 (1) 23-32; DOI: https://doi.org/10.1681/ASN.V7123
    2. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
      P H Nachman, S L Hogan, J C Jennette and R J Falk
      JASN January 1996, 7 (1) 33-39; DOI: https://doi.org/10.1681/ASN.V7133

  3. Juncos, L A

    1. Platelet-activating factor dilates efferent arterioles through glomerulus-derived nitric oxide.
      S Arima, Y Ren, L A Juncos and S Ito
      JASN January 1996, 7 (1) 90-96; DOI: https://doi.org/10.1681/ASN.V7190

K

  1. Kasiske, B L

    1. Cardiovascular disease after renal transplantation.
      B L Kasiske, C Guijarro, Z A Massy, M R Wiederkehr and J Z Ma
      JASN January 1996, 7 (1) 158-165; DOI: https://doi.org/10.1681/ASN.V71158

  2. Klotman, P E

    1. Are we missing an epidemic of HIV-associated nephropathy?
      J A Winston and P E Klotman
      JASN January 1996, 7 (1) 1-7; DOI: https://doi.org/10.1681/ASN.V711

L

  1. Liao, S Y

    1. Urinary concentrating defect in experimental hemochromatosis.
      X J Zhou, N D Vaziri, D Pandian, Z Q Wang, M Mazowiecki, S Y Liao and F Oveisi
      JASN January 1996, 7 (1) 128-134; DOI: https://doi.org/10.1681/ASN.V71128

  2. Lieberman, K V

    1. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children.
      K V Lieberman and A Tejani
      JASN January 1996, 7 (1) 56-63; DOI: https://doi.org/10.1681/ASN.V7156

  3. Ling, H

    1. Role of lysosomal cathepsin activities in cell hypertrophy induced by NH4Cl in cultured renal proximal tubule cells.
      H Ling, S Vamvakas, M Gekle, L Schaefer, M Teschner, R M Schaefer and A Heidland
      JASN January 1996, 7 (1) 73-80; DOI: https://doi.org/10.1681/ASN.V7173

  4. Luft, F C

    1. Circulating leukocyte integrin expression in Wegener's granulomatosis.
      H Haller, J Eichhorn, K Pieper, U Göbel and F C Luft
      JASN January 1996, 7 (1) 40-48; DOI: https://doi.org/10.1681/ASN.V7140

  5. Ly, H

    1. Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats.
      S J Shankland, H Ly, K Thai and J W Scholey
      JASN January 1996, 7 (1) 97-104; DOI: https://doi.org/10.1681/ASN.V7197

M

  1. Ma, J Z

    1. Cardiovascular disease after renal transplantation.
      B L Kasiske, C Guijarro, Z A Massy, M R Wiederkehr and J Z Ma
      JASN January 1996, 7 (1) 158-165; DOI: https://doi.org/10.1681/ASN.V71158

  2. Magri, P

    1. Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis.
      G Fuiano, N Comi, P Magri, V Sepe, M M Balletta, C Esposito, F Uccello, A Dal Canton and G Conte
      JASN January 1996, 7 (1) 49-55; DOI: https://doi.org/10.1681/ASN.V7149

  3. Maioli, M

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

  4. Marcen, R

    1. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study.
      J L Teruel, R Marcen, J Navarro-Antolin, A Aguilera, G Fernandez-Juarez and J Ortuño
      JASN January 1996, 7 (1) 140-144; DOI: https://doi.org/10.1681/ASN.V71140

  5. Marin Castaño, M E

    1. Postnatal maturation of the Kallikrein-kinin system in the rat kidney: from enzyme activity to receptor gene expression.
      J L Bascands, M E Marin Castaño, G Bompart, C Pecher, M Gaucher and J P Girolami
      JASN January 1996, 7 (1) 81-89; DOI: https://doi.org/10.1681/ASN.V7181

  6. Massy, Z A

    1. Cardiovascular disease after renal transplantation.
      B L Kasiske, C Guijarro, Z A Massy, M R Wiederkehr and J Z Ma
      JASN January 1996, 7 (1) 158-165; DOI: https://doi.org/10.1681/ASN.V71158

  7. Mathis, K M

    1. Role of nitric oxide and angiotensin II in diabetes mellitus-induced glomerular hyperfiltration.
      K M Mathis and R O Banks
      JASN January 1996, 7 (1) 105-112; DOI: https://doi.org/10.1681/ASN.V71105

  8. Mazowiecki, M

    1. Urinary concentrating defect in experimental hemochromatosis.
      X J Zhou, N D Vaziri, D Pandian, Z Q Wang, M Mazowiecki, S Y Liao and F Oveisi
      JASN January 1996, 7 (1) 128-134; DOI: https://doi.org/10.1681/ASN.V71128

N

  1. Nachman, P H

    1. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
      S L Hogan, P H Nachman, A S Wilkman, J C Jennette and R J Falk
      JASN January 1996, 7 (1) 23-32; DOI: https://doi.org/10.1681/ASN.V7123
    2. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
      P H Nachman, S L Hogan, J C Jennette and R J Falk
      JASN January 1996, 7 (1) 33-39; DOI: https://doi.org/10.1681/ASN.V7133

  2. Navarro-Antolin, J

    1. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study.
      J L Teruel, R Marcen, J Navarro-Antolin, A Aguilera, G Fernandez-Juarez and J Ortuño
      JASN January 1996, 7 (1) 140-144; DOI: https://doi.org/10.1681/ASN.V71140

  3. Nosadini, R

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

O

  1. Olaizola, I

    1. Influence of iron status in the response to the deferoxamine test.
      J B Cannata, J L Fernández-Martín, B Díaz-López, M Alonso, I Olaizola, G Acuña, C Caramelo and J Alvarez-Grande
      JASN January 1996, 7 (1) 135-139; DOI: https://doi.org/10.1681/ASN.V71135

  2. Ortuño, J

    1. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study.
      J L Teruel, R Marcen, J Navarro-Antolin, A Aguilera, G Fernandez-Juarez and J Ortuño
      JASN January 1996, 7 (1) 140-144; DOI: https://doi.org/10.1681/ASN.V71140

  3. Oveisi, F

    1. Urinary concentrating defect in experimental hemochromatosis.
      X J Zhou, N D Vaziri, D Pandian, Z Q Wang, M Mazowiecki, S Y Liao and F Oveisi
      JASN January 1996, 7 (1) 128-134; DOI: https://doi.org/10.1681/ASN.V71128

P

  1. Pacini, G

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

  2. Pandian, D

    1. Urinary concentrating defect in experimental hemochromatosis.
      X J Zhou, N D Vaziri, D Pandian, Z Q Wang, M Mazowiecki, S Y Liao and F Oveisi
      JASN January 1996, 7 (1) 128-134; DOI: https://doi.org/10.1681/ASN.V71128

  3. Pecher, C

    1. Postnatal maturation of the Kallikrein-kinin system in the rat kidney: from enzyme activity to receptor gene expression.
      J L Bascands, M E Marin Castaño, G Bompart, C Pecher, M Gaucher and J P Girolami
      JASN January 1996, 7 (1) 81-89; DOI: https://doi.org/10.1681/ASN.V7181

  4. Pieper, K

    1. Circulating leukocyte integrin expression in Wegener's granulomatosis.
      H Haller, J Eichhorn, K Pieper, U Göbel and F C Luft
      JASN January 1996, 7 (1) 40-48; DOI: https://doi.org/10.1681/ASN.V7140

R

  1. Ren, Y

    1. Platelet-activating factor dilates efferent arterioles through glomerulus-derived nitric oxide.
      S Arima, Y Ren, L A Juncos and S Ito
      JASN January 1996, 7 (1) 90-96; DOI: https://doi.org/10.1681/ASN.V7190

  2. Robaudo, C

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

  3. Roth, D

    1. Recipient body size and cadaveric renal allograft survival.
      H I Feldman, I Fazio, D Roth, J A Berlin, K Brayman, J E Burns and R A Grossman
      JASN January 1996, 7 (1) 151-157; DOI: https://doi.org/10.1681/ASN.V71151

S

  1. Sambataro, M

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

  2. Schaefer, L

    1. Role of lysosomal cathepsin activities in cell hypertrophy induced by NH4Cl in cultured renal proximal tubule cells.
      H Ling, S Vamvakas, M Gekle, L Schaefer, M Teschner, R M Schaefer and A Heidland
      JASN January 1996, 7 (1) 73-80; DOI: https://doi.org/10.1681/ASN.V7173

  3. Schaefer, R M

    1. Role of lysosomal cathepsin activities in cell hypertrophy induced by NH4Cl in cultured renal proximal tubule cells.
      H Ling, S Vamvakas, M Gekle, L Schaefer, M Teschner, R M Schaefer and A Heidland
      JASN January 1996, 7 (1) 73-80; DOI: https://doi.org/10.1681/ASN.V7173

  4. Scholey, J W

    1. Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats.
      S J Shankland, H Ly, K Thai and J W Scholey
      JASN January 1996, 7 (1) 97-104; DOI: https://doi.org/10.1681/ASN.V7197

  5. Sepe, V

    1. Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis.
      G Fuiano, N Comi, P Magri, V Sepe, M M Balletta, C Esposito, F Uccello, A Dal Canton and G Conte
      JASN January 1996, 7 (1) 49-55; DOI: https://doi.org/10.1681/ASN.V7149

  6. Shankland, S J

    1. Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats.
      S J Shankland, H Ly, K Thai and J W Scholey
      JASN January 1996, 7 (1) 97-104; DOI: https://doi.org/10.1681/ASN.V7197

  7. Stolk, B

    1. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage.
      J van de Wetering, R G Westendorp, J G van der Hoeven, B Stolk, J D Feuth and P C Chang
      JASN January 1996, 7 (1) 145-150; DOI: https://doi.org/10.1681/ASN.V71145

T

  1. Tejani, A

    1. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children.
      K V Lieberman and A Tejani
      JASN January 1996, 7 (1) 56-63; DOI: https://doi.org/10.1681/ASN.V7156

  2. Teruel, J L

    1. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study.
      J L Teruel, R Marcen, J Navarro-Antolin, A Aguilera, G Fernandez-Juarez and J Ortuño
      JASN January 1996, 7 (1) 140-144; DOI: https://doi.org/10.1681/ASN.V71140

  3. Teschner, M

    1. Role of lysosomal cathepsin activities in cell hypertrophy induced by NH4Cl in cultured renal proximal tubule cells.
      H Ling, S Vamvakas, M Gekle, L Schaefer, M Teschner, R M Schaefer and A Heidland
      JASN January 1996, 7 (1) 73-80; DOI: https://doi.org/10.1681/ASN.V7173

  4. Thai, K

    1. Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats.
      S J Shankland, H Ly, K Thai and J W Scholey
      JASN January 1996, 7 (1) 97-104; DOI: https://doi.org/10.1681/ASN.V7197

  5. Thomaseth, K

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

  6. Tonolo, G C

    1. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
      M Sambataro, K Thomaseth, G Pacini, C Robaudo, A Carraro, M Bruseghin, E Brocco, C Abaterusso, G DeFerrari, P Fioretto, M Maioli, G C Tonolo, G Crepaldi and R Nosadini
      JASN January 1996, 7 (1) 118-127; DOI: https://doi.org/10.1681/ASN.V71118

U

  1. Uccello, F

    1. Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis.
      G Fuiano, N Comi, P Magri, V Sepe, M M Balletta, C Esposito, F Uccello, A Dal Canton and G Conte
      JASN January 1996, 7 (1) 49-55; DOI: https://doi.org/10.1681/ASN.V7149

  2. Uehlinger, D E

    1. Another look at the relationship between protein intake and dialysis dose.
      D E Uehlinger
      JASN January 1996, 7 (1) 166-168; DOI: https://doi.org/10.1681/ASN.V71166

V

  1. Vamvakas, S

    1. Role of lysosomal cathepsin activities in cell hypertrophy induced by NH4Cl in cultured renal proximal tubule cells.
      H Ling, S Vamvakas, M Gekle, L Schaefer, M Teschner, R M Schaefer and A Heidland
      JASN January 1996, 7 (1) 73-80; DOI: https://doi.org/10.1681/ASN.V7173

  2. van der Hoeven, J G

    1. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage.
      J van de Wetering, R G Westendorp, J G van der Hoeven, B Stolk, J D Feuth and P C Chang
      JASN January 1996, 7 (1) 145-150; DOI: https://doi.org/10.1681/ASN.V71145

  3. van de Wetering, J

    1. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage.
      J van de Wetering, R G Westendorp, J G van der Hoeven, B Stolk, J D Feuth and P C Chang
      JASN January 1996, 7 (1) 145-150; DOI: https://doi.org/10.1681/ASN.V71145

  4. Vaziri, N D

    1. Urinary concentrating defect in experimental hemochromatosis.
      X J Zhou, N D Vaziri, D Pandian, Z Q Wang, M Mazowiecki, S Y Liao and F Oveisi
      JASN January 1996, 7 (1) 128-134; DOI: https://doi.org/10.1681/ASN.V71128

  5. Vora, J P

    1. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes.
      J P Vora, S M Zimsen, D C Houghton and S Anderson
      JASN January 1996, 7 (1) 113-117; DOI: https://doi.org/10.1681/ASN.V71113

W

  1. Wang, Z Q

    1. Urinary concentrating defect in experimental hemochromatosis.
      X J Zhou, N D Vaziri, D Pandian, Z Q Wang, M Mazowiecki, S Y Liao and F Oveisi
      JASN January 1996, 7 (1) 128-134; DOI: https://doi.org/10.1681/ASN.V71128

  2. Westendorp, R G

    1. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage.
      J van de Wetering, R G Westendorp, J G van der Hoeven, B Stolk, J D Feuth and P C Chang
      JASN January 1996, 7 (1) 145-150; DOI: https://doi.org/10.1681/ASN.V71145

  3. Wiederkehr, M R

    1. Cardiovascular disease after renal transplantation.
      B L Kasiske, C Guijarro, Z A Massy, M R Wiederkehr and J Z Ma
      JASN January 1996, 7 (1) 158-165; DOI: https://doi.org/10.1681/ASN.V71158

  4. Wilkman, A S

    1. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
      S L Hogan, P H Nachman, A S Wilkman, J C Jennette and R J Falk
      JASN January 1996, 7 (1) 23-32; DOI: https://doi.org/10.1681/ASN.V7123

  5. Winston, J A

    1. Are we missing an epidemic of HIV-associated nephropathy?
      J A Winston and P E Klotman
      JASN January 1996, 7 (1) 1-7; DOI: https://doi.org/10.1681/ASN.V711

Z

  1. Zager, R A

    1. Phospholipase A2-induced cytoprotection of proximal tubules: potential determinants and specificity for ATP depletion-mediated injury.
      R A Zager, K M Burkhart, D S Conrad, D J Gmur and M Iwata
      JASN January 1996, 7 (1) 64-72; DOI: https://doi.org/10.1681/ASN.V7164

  2. Zhou, X J

    1. Urinary concentrating defect in experimental hemochromatosis.
      X J Zhou, N D Vaziri, D Pandian, Z Q Wang, M Mazowiecki, S Y Liao and F Oveisi
      JASN January 1996, 7 (1) 128-134; DOI: https://doi.org/10.1681/ASN.V71128

  3. Zimsen, S M

    1. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes.
      J P Vora, S M Zimsen, D C Houghton and S Anderson
      JASN January 1996, 7 (1) 113-117; DOI: https://doi.org/10.1681/ASN.V71113
Back to top

In this issue

View Selected Citations (0)